Onyx Pharmaceuticals buy wiltrud
Start price
30.03.12
/
50%
€28.37
Target price
25.04.12
€34.50
Performance (%)
23.94%
End price
25.04.12
€35.16
Summary
This prediction ended on 25.04.12 with a price of €35.16. The prediction had a final performance of 23.94%. wiltrud has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Onyx Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by wiltrud for this prediction
In the thread Onyx Pharmaceuticals diskutieren
Bekommt Onyx die zweite Zulassung ?
kalifornische Biotech-Unternehmen steht vor der Zulassung seines zweiten Medikaments. Ein Erfolg könnte zu steigenden Kursen führen.
<!-- /BLOCK 4 -->